Alleviation of experimental ulcerative colitis with the synthetic peptide, F2A4-K-NS (Fibratide)

Digestive Diseases and Sciences

Volumn 52, Issue 9, 2007, Pages 2054-2062

  Lin, Xinhua ^a   Zamora, Paul O ^a   Takahashi, Kazu ^a   Lui, Yi ^a  

^a BioSurface Engineering Technologies Inc   (United States)

Author keywords

Epithelial; Growth factor; Mimetic peptide; Oral delivery; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; F2A4 K NS; FIBRATIDE; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT FIBROBLAST GROWTH FACTOR 2; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; CELL MIGRATION; CELL PROLIFERATION; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ENTERITIS; FEMALE; HISTOLOGY; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; INTESTINE WALL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; THICKNESS; TREATMENT OUTCOME; ULCERATIVE COLITIS; WEIGHT REDUCTION; WOUND HEALING;

ADMINISTRATION, ORAL; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLITIS, ULCERATIVE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLAST GROWTH FACTOR 2; INJECTIONS, INTRAPERITONEAL; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; PLASMA SUBSTITUTES; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 34547851728     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9641-z     Document Type: Article

References (33)

1. Rutgeerts P, Vermeire S (2006) Review article:infliximab therapy for inflammatory bowel disease-seven years on. Aliment Pharmacol Ther 23:451-463
2. Hull MA, Cullen DJ, Hudson N, Hawkey CJ (1995) Basic fibroblast growth factor treatment for non-steroidal anti-inflammatory drug associated gastric ulceration. Gut 37:610-612
3. Kusstatscher S, Sandor Z, Szabo S, Seddon A, Bohlen P (1995) Different molecular forms of basic fibroblast growth factor (bFGF) accelerate duodenal ulcer healing in rats. J Pharmacol Exp Ther 275:456-461
4. Satoh H, Asano S, Maeda R, Murakami I, Inada I, Sato F, Shino A (1997) Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor. Jpn J Pharmacol 73:229-241
5. Satoh H, Shino A, Sato F, Asano S, Murakami I, Inatomi N, Nagaya H, Kato K, Szabo S, Folkman J (1997) Role of endogenous basic fibroblast growth factor in the healing of gastric ulcers in rats. Jpn J Pharmacol 73:59-71
6. Szabo S, Folkman J, Vattay P, Morales RE, Pinkus GS, Kato K (1994) Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats. Gastroenterology 106:1106-1111
7. Howarth GS, Xian CJ, Read LC (1998) Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium. Scand J Gastroenterol 33:180-190
8. Jeffers M, McDonald WF, Chillakuru RA, Yang M, Nakase H, Deegler LL, Sylander ED, Rittman B, Bendele A, Sartor RB, Lichenstein HS (2002) A novel human fibroblast growth factor treats experimental intestinal inflammation. Gastroenterology 123:1151-1162
9. Matsuura M, Okazaki K, Nishio A, Nakase H, Tamaki H, Uchida K, Nishi T, Asada M, Kawasaki K, Fukui T, Yoshizawa H, Ohashi S, Inoue S, Kawanami C, Hiai H, Tabata Y, Chiba T (2005) Therapeutic effects of rectal administration of basic fibroblast growth factor on experimental murine colitis. Gastroenterology 128:975-986
10. Sinha A, Nightingale J, West KP, Berlanga-Acosta J, Playford RJ (2003) Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med 349:350-357
11. Zeeh JM, Procaccino F, Hoffmann P, Aukerman SL, McRoberts JA, Soltani S, Pierce GF, Lakshmanan J, Lacey D, Eysselein VE (1996) Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 110:1077-1083
12. Beck PL, Podolsky DK (1999) Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 5:44-60
13. Finch PW, Cheng AL (1999) Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut 45:848-855
14. Finch PW, Pricolo V, Wu A, Finkelstein SD (1996) Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology 110:441-451
15. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K (2001) VEGF, basic-FGF, TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96:822-828
16. Lin X, Takahashi K, Campion SL, Liu Y, Gustavsen GG, Pena LA, Zamora PO (2006) Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo International. J Mol Med 17:833-841
17. Williams KL, Fuller CR, Dieleman LA, DaCosta CM, Haldeman KM, Sartor RB, Lund PK (2001) Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120:925-937
18. Ciacci C, Lind SE, Podolsky DK (1993) Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 105:93-101
19. Arakawa T, Wen J, Philo JS (1993) Densimetric determination of equilibrium binding of sucrose octasulfate with basic fibroblast growth factor. J Protein Chem 12:689-693
20. Volkin DB, Verticelli AM, Marfia KE, Burke CJ, Mach H, Middaugh CR (1993) Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor. Biochim Biophys Acta 1203:18-26
21. Maj JG, Paris F, Haimovitz-Friedman A, Venkatraman E, Kolesnick R, Fuks Z (2003) Microvascular function regulates intestinal crypt response to radiation. Cancer Res 63:4338-4341
22. Okunieff P, Mester M, Wang J, Maddox T, Gong X, Tang D, Coffee M, Ding I (1998) In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat Res 150:204-211
23. Alvarez E, Fey EG, Valax P, Yim Z, Peterson JD, Mesri M, Jeffers M, Dindinger M, Twomlow N, Ghatpande A, LaRochelle WJ, Sonis ST, Lichenstein HS (2003) Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis. Clin Cancer Res 9:3454-3461
24. Dorr W, Reichel S, Spekl K (2005) Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother Oncol 75:99-105
25. Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, Havill AM, Lu ZN, Aukerman SL, Pierce GF, Thomason A, Potten CS, Ulich TR, Lacey DL (1998) Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58:933-939
26. Farrell CL, Rex KL, Chen JN, Bready JV, DiPalma CR, Kaufman SA, Rattan A, Scully S, Lacey DL (2002) The effects of keratinocyte growth factor in preclinical models of mucositis. Cell Prolif 35 (Suppl 1):78-85
27. Miceli R, Hubert M, Santiago G, Yao DL, Coleman TA, Huddleston KA, Connolly K (1999) Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis. J Pharmacol Exp Ther 290:464-471
28. Dignass AU, Tsunekawa S, Podolsky DK (1994) Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 106:1254-1262
29. Houchen CW, George RJ, Sturmoski MA, Cohn SM (1999) FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol 276:G249-G258
30. Boismenu R, Chen Y, Chou K, El-Sheikh A, Buelow R (2002) Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis. Ann Rheum Dis 61 (Suppl 2):ii19-ii24
31. Travis S, Yap LM, Hawkey C, Warren B, Lazarov M, Fong T, Tesi RJ (2005) RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. Inflamm Bowel Dis 11:713-719
32. Gonzalez-Rey E, Fernandez-Martin A, Chorny A, Delgado M (2006) Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut (in press)
33. Gonzalez-Rey E, Varela N, Sheibanie AF, Chorny A, Ganea D, Delgado M (2006) Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proc Natl Acad Sci USA 103:4228-4233